Sian Hsiang-Te Tsuei

Sian Hsiang-Te Tsuei

Auto-generated profile, based on publicly available information

Sian Hsiang-Te Tsuei

Department of Family Practice, University of British Columbia, Vancouver, British Columbia, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2024 in The Lancet Regional Health - Western Pacific
Verified
Journal Article
Open access
TCTiange Chen
Tiange Chen
XSXuefeng Sun
Xuefeng Sun
STSian Tsuei
Sian Tsuei
RYRuirui Yang
Ruirui Yang
WYWinnie Yip
Winnie Yip
HFHongqiao Fu
Hongqiao Fu
This review comprehensively evaluates China’s progress in care of end-stage kidney disease (ESKD) by identifying achievements and gaps, reviewing ESKD-related policy initiatives, and proposing policy recommendations. In the past decade, China has made laudable progress in access to ESKD care with narrowed difference between the number of patients needing and receiving kidney replacement therapies (KRT). China has also experienced significant improvements in clinical quality and outcomes of ESKD care. These achievements stem from concerted efforts in advocating effective policies, increasing fiscal subsidies, re-designing health insurance schemes, encouraging healthcare delivery from both public and private sectors, and improving quality regulation. However, challenges remain, including inequitable access to care across regions and groups, and suboptimal quality and outcomes in some underdeveloped areas. To address these gaps, we recommend reforming the financing policy, adopting quality-based payment methods, strengthening quality monitoring system, improving chronic kidney disease prevention and management, and developing alternative KRT modalities.

1 August 2024 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
STSian Hsiang-Te Tsuei
Sian Hsiang-Te Tsuei
On the eve of Taiwan's National Health Insurance's 30th birthday, this study reviews the policy and performance trajectory of the Taiwanese health system. Taiwan has controlled their health spending well and grown increasingly reliant on private financing. The floating-point global budget payment preferentially rewards outpatient-based services, but this has not affected the hospital-centric market composition, which persists despite several primary-care friendly developments. The outcomes suggest improving health care workforce and resource availability, good patient-centredness, respectable technical efficiency, and impressive patient care satisfaction. However, there are worrisome trends for financial barriers to access and allocative efficiency. Evidence on clinical quality suggests that hospitals are performing well though the primary care setting might not be. Overall, the public remains satisfied despite signs of lagging improvement in health outcomes, worsening maternal mortality rate, and persistently incomplete financial risk protection. Identifying what drives the worsening financial barriers of access and persistent financial risk is necessary for further discussions on potential financing adjustments. Improving allocative efficiency could draw on a combination of supporting the functions and quality of primary care alongside patient-oriented education and incentives. Further data on causes of slow health status improvement and rebounding maternal mortality rate is necessary.

23 September 2020 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
STSian Hsiang-Te Tsuei
Sian Hsiang-Te Tsuei
Introduction There has been little systematic exploration into what affects timeliness of epidemic response, despite the potential for earlier responses to be more effective. Speculations have circulated that previous exposure to major epidemics helped health systems respond more quickly to COVID-19. This study leverages organisational memory theory to test whether health systems with any, more severe, or more recent exposure to major epidemics enacted timelier COVID-19 policy responses. Methods A data set was constructed cataloguing 846 policies across 178 health systems in total, 37 of which had major epidemics within the last 20 years. Hypothesis testing used OLS regressions with World Health Organization region fixed effects, controlling for several health system expenditure and political variables. Results Results show that exposure to any major epidemics was associated with providing earlier response in the following policy categories: all policies, surveillance/response, distancing, and international travel policies. The effect was about 6–10 days earlier response. The significance of this variable was largely nullified with the addition of the other two independent variables. Neither total cases nor years since previous epidemics showed no statistical significance. Conclusion This study suggests that health systems may learn from past major epidemics. Policymakers ought to institutionalise lessons from COVID-19. Future studies can examine specific generalisable lessons and whether timelier responses correlated with lower health and economic impacts.

6 January 2026 in JMIR Medical Education
Verified
Journal Article
Open access
CLChunqing Li
Chunqing Li
STSian Hsiang-Te Tsuei
Sian Hsiang-Te Tsuei
HWHongbin Wu
Hongbin Wu
Background: Artificial intelligence (AI) literacy is increasingly essential for medical students. However, without systematic characterization of the relevant components, designing targeted medical education interventions may be challenging. Objective: This study aimed to systematically describe the levels of and factors associated with multidimensional AI literacy among Chinese medical students. Methods: A cross-sectional, descriptive analysis was conducted using data from a nationwide survey of Chinese medical students (N=80,335) across 109 medical schools in 2024. AI literacy was assessed with a multidimensional instrument comprising three domains: knowledge, evaluating students’ self-reported proficiency in core areas of medical AI applications; attitude, reflecting their self-perceived views on using AI for teaching and learning; and behavior, capturing the self-perceived usage frequency and application patterns. Multivariate linear regression was applied to examine the associations between individual factors (ie, demographic characteristics, family background, and enrollment motivation) and environmental factors (ie, educational phase, type of education program, and tier of education program) and AI literacy. Results: Respondents showed moderate to high levels of AI knowledge (mean 76.0, SD 26.9), followed by moderate AI attitude scores (mean 71.6, SD, 24.4). In contrast, AI behavior scores were much lower (mean 32.5, SD, 28.5), indicating little usage of AI tools. Of the individual factors, male students reported higher levels of AI attitude and behavior; both intrinsic and extrinsic motivation were positively associated with all three dimensions; advantaged family background was positively related to AI attitude and behavior, but not knowledge. Among the environmental factors, attending the prestigious Double First-Class universities was positively associated with higher AI usage. Enrollment in long-track medical education programs was associated with higher AI attitude and behavior, while being in the clinical phase was negatively associated with both AI knowledge and behavior. Environmental factors moderated the associations between individual characteristics and AI literacy, potentially attenuating disparities. Conclusions: Medical students reported moderate to high AI knowledge, moderate AI favorability, and low AI use. Individual characteristics and environmental factors were significantly associated with AI literacy, and environmental factors moderated the associations. The moderate AI literacy overall highlights the need for AI-related medical education, ideally with practical use and nuanced by socioeconomic factors.

13 May 2024 in The International Journal of Health Planning and Management
Verified
Journal Article
Open access
STSian Hsiang‐Te Tsuei
Sian Hsiang‐Te Tsuei
WYWinnie (Chi‐Man) Yip
Winnie (Chi‐Man) Yip
Background: Provider payment reforms (PPRs) have demonstrated mixed results for improving health system efficiency. Since PPRs require health care organisations to interpret and implement policies, the organizational characteristics of hospitals may affect the effectiveness of PPRs. Hospitals with more autonomy have the flexibility to respond to PPRs more efficiently, but they may not if the autonomy previously facilitated behaviours that counter the PPR's objective. This study examines whether hospitals with higher autonomy responds to PPRs more effectively.Methods: We used data from a matched‐pair, cluster randomized controlled PPR intervention in a resource‐limited Chinese province between 2014 and 2018. The intervention reformed the reimbursement method from the publicly administered New Cooperative Medical Scheme (NCMS) from fee‐for‐service to global budget. We interacted measures of hospital autonomy over surplus, hiring, and procurement (drugs, consumables, equipment, and overall index) with the difference‐in‐difference estimator to examine how autonomy moderated the intervention's effect.Results: Autonomy over surplus (p < 0.01) and procurement of equipment (p < 0.01) were associated with relatively faster NCMS expenditure growth, demonstrating worse PPR response. They were also associated with higher expenditure shifting to out‐of‐pocket expenditures (p > 0.05). Post hoc analysis suggests that hospitals with surplus autonomy had higher OOP per admission (p < 0.01), suggesting profiteering tendencies. Other dimensions of autonomy demonstrated imprecise association.Discussion: Hospitals with more autonomy may not necessarily respond more effectively to PPRs that incentivise efficiency when they had previously been encouraged to maximise profit. Policymakers should assess the extent of perverse incentives before granting autonomy and adjust the incentives accordingly.

18 February 2025 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
AHAnnie Haakenstad
Annie Haakenstad
AKAnuska Kalita
Anuska Kalita
BBBijetri Bose
Bijetri Bose
ACArpita Chakraborty
Arpita Chakraborty
KGKirti Gupta
Kirti Gupta
WYWinnie Yip
Winnie Yip
Introduction: In India, public sector patients purchase drugs from private pharmacies instead of obtaining them for free from public pharmacies—a phenomenon we call public patient forwarding to private pharmacies. This behaviour results in substantial financial hardship. We examine whether low public drug stocks, patient preferences for private drugs or the presence of private pharmacies nearby explain this behaviour.Methods: We collected cross-sectional data from 7567 households, 523 health facilities and 1036 private pharmacies in Odisha, India. We linked 917 outpatient visits to facilities based on patient reports and linked public facilities to the nearest private pharmacy using Global Positioning System coordinates. We used ordinary least squares regression to assess whether the behaviour of facilities and patients was associated with drug stocks and pharmacy proximity, and whether patient satisfaction was associated with private drug purchases.Results: Among public patients prescribed drugs, more than 70% purchased private drugs. In hospitals, for each 10% increase in drug stocks, 4.8% fewer patients purchased private drugs (p=0.047). In primary facilities, the same share of patients purchased private drugs across stock levels. Regardless of facility level, when more than 75% of drugs were in stock, 60% or more of patients still obtained drugs from the private sector. Patients were more likely to purchase private drugs when private pharmacies were near public facilities, but were not more satisfied with their visit when they obtained private drugs.Conclusion: The results suggest that private pharmacies are both secondary and complementary suppliers of drugs for hospitals, but may act more like substitutes for primary facilities, consistent with evidence that private pharmacies provide advice and other services akin to primary care in Odisha. Improving public facility drug stocks alone is unlikely to fully address drug-driven financial hardship in India. Provider prescribing practices should be investigated to identify additional policy options.